Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Solifenacin succinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for solifenacin succinate and what is the scope of solifenacin succinate patent protection?

Solifenacin succinate
is the generic ingredient in two branded drugs marketed by Astellas and Teva Pharms Usa, and is included in two NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Solifenacin succinate has thirty-one patent family members in twenty-two countries.

There are twenty-nine drug master file entries for solifenacin succinate. Four suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: solifenacin succinate

Drug Master File Entries: see list29
Suppliers / Packagers: see list4
Bulk Api Vendors: see list68
Clinical Trials: see list97
Patent Applications: see list1,828
Therapeutic Class:Genitourinary Agents
Drug Prices:see low prices
DailyMed Link:solifenacin succinate at DailyMed

Pharmacology for Ingredient: solifenacin succinate

Tentative approvals for SOLIFENACIN SUCCINATE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe5MGTABLET;ORAL
► Subscribe► Subscribe10MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
solifenacin succinate
TABLET;ORAL091464-001Apr 2, 2014ABRXNoNo► Subscribe► Subscribe
solifenacin succinate
TABLET;ORAL021518-001Nov 19, 2004ABRXYesNo6,017,927► SubscribeYY ► Subscribe
Teva Pharms Usa
solifenacin succinate
TABLET;ORAL091464-002Apr 2, 2014ABRXNoNo► Subscribe► Subscribe
solifenacin succinate
TABLET;ORAL021518-002Nov 19, 2004ABRXYesYes6,017,927► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus